Diabetes, Low eGFR & Kidney Failure Risk
- This text is an excerpt from an article published in Nephrology News & Issues (via Healio) discussing a study on cardiorenal disease adn kidney failure risk in individuals...
- * Individuals with diabetes who had a baseline eGFR of less than .73 m were at higher risk for kidney failure and death.
- * Lance Sloan, MD, MSE, FACE, FASN, FACP, FASPC, FEAA is a member of the Healio | Nephrology news & Issues Editorial Advisory Board and President of the...
Summary of the Provided Text:
This text is an excerpt from an article published in Nephrology News & Issues (via Healio) discussing a study on cardiorenal disease adn kidney failure risk in individuals with diabetes.
Key Findings:
* Individuals with diabetes who had a baseline eGFR of less than .73 m were at higher risk for kidney failure and death.
* Higher risk was also associated with being male, a race other than white, older age, and having noncommercial health insurance or hospitalization in the year prior to follow-up.
* These findings are expected given the known increased risks of death and kidney dysfunction in people with diabetes, which impacts immune function.
* The article emphasizes the importance of aggressive treatment of cardiorenal disease using SGLT2 inhibitors,GLP-1 receptor agonists,and renin-angiotensin-aldosterone system inhibitors,along with addressing other cardiorenal risk factors.
Author Data:
* Lance Sloan, MD, MSE, FACE, FASN, FACP, FASPC, FEAA is a member of the Healio | Nephrology news & Issues Editorial Advisory Board and President of the Texas Institute for Kidney and Endocrine Disorders.
* He has extensive financial disclosures,including advisory board memberships,speaker bureau engagements,and research funding from numerous pharmaceutical companies (bayer,Corcept,Idorsia,Novo Nordisk,Pfizer,AstraZeneca,Boehringer Ingelheim,Lilly,Sanofi,Xeris,Amgen,Merck).
Additional Disclosure:
* Another author, Tuttle, also has significant financial disclosures related to grants, consultant fees, speaker fees, data safety monitoring board roles, and leadership positions within the American Society of Nephrology.